Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CardiolRxTM in Recurrent Pericarditis (MAVERIC Phase 3) A Randomized, Double-blind, Placebo-controlled Trial

NCT06708299 is registered in ClinicalTrials.gov with Cardiol Therapeutics Inc. as lead sponsor.

NCT NCT06708299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06708299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CardiolRxTM in Recurrent Pericarditis (MAVERIC Phase 3) A Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Cardiol Therapeutics Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
April 7, 2025
Completion date
October 21, 2026
Enrollment
110 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pericarditis